PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Recruiting · NCT06961565 · Registry updated 2025-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibroma | Recruiting | Phase 1 | 2025-12-04 | NCT06961565 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novotech (Australia) Pty Limited | 15 |
| Pasithea Therapeutics Corp. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Royal North Shore Hospital | St Leonards | Australia | 50 |
| Severance Hospital, Yonsei University Health System | Sinchŏn-dong | South Korea | 1 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |